As we prepare for the 4th of July holiday a few thoughts on all the wackiness that has been going on recently in the diabetes toy sector. First comes the FDA approval of the Libre2 with an iCGM designation. Next Abbott and Tandem finalize their agreement to find ways for the Libre to work with Tandem systems. And the biggie Tandem receives coverage from UnitedHealthcare after Medtronic announces their exclusive arrangement has been changed.
Just as an FYI in a note to analysts Medtronic did their best to put a positive spin on the United news stating- “our agreement is . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.